| HOME >> BIOLOGY >> TECHNOLOGY |
Depreciation 579,754 417,406
Amortization 53,192 23,686
Loss on disposal of
equipment 1,900 4,064
Stock-based compensation 1,263,188 --
Change in operating assets
and liabilities:
Accounts receivable (477,858) 458,758
Notes receivable (23,694) 57,721
Other receivables (201,576) (1,317,291)
Other receivables -
shareholders 1,419 (146,149)
Inventories (2,571,137) (989,274)
Prepayments and deferred
expenses (241,377) 187,928
Accounts payable (294,290) 36,733
Other payables and
accrued liabilities 683,527 298,787
Other payable - land use
right (752) --
Customer deposits 264,990 1,239,099
Taxes payable 2,134,302 547,273
Contingent liability (107,273) --
Net cash provided
by operating activities 6,623,033 7,309,632
CASH FLOWS FROM INVESTING
ACTIVITIES:
Additions to plant and equipment (2,245,627) (3,830,236)
Additions to construction in progress -- 9,393
Additions to intangible assets (9,517) (46,213)
Proceeds from sale
'/>"/>
| SOURCE China Biologic Products, Inc. Copyright©2008 PR Newswire. All rights reserved |